|4Feb 13, 6:17 PM ET

REGENERX BIOPHARMACEUTICALS INC 4

4 · REGENERX BIOPHARMACEUTICALS INC · Filed Feb 13, 2015

Insider Transaction Report

Form 4
Period: 2015-02-11
Bove Mauro
Director
Transactions
  • Award

    Stock Option (right to buy)

    2015-02-11+100,000100,000 total
    Exercise: $0.19Exp: 2022-02-11Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]The option vests 25,000 shares annually beginning on February 11, 2016.

Documents

2 files
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT

  • EX-24

    BOVE POWER OF ATTORNEY